Qualitative and quantitative measurements of oligonucleotides in gene therapy: Part II in vivo models
- 1 May 1997
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 15 (8) , 1127-1135
- https://doi.org/10.1016/s0731-7085(97)01942-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Pharmacokinetics, Biodistribution, and Stability of Capped Oligodeoxynucleotide Phosphorothioates in MiceAntisense Research and Development, 1993
- Capped Oligodeoxynucleotide Phosphorothioates.Annals of the New York Academy of Sciences, 1992
- High-performance liquid chromatography determination of polydeoxyribonucleotides in plasma: Its application to the determination of defibrotide's pharmacokinetics in the rabbitAnalytical Biochemistry, 1992
- Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in miceBiopharmaceutics & Drug Disposition, 1992
- In vivostability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotidesNucleic Acids Research, 1992
- Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distributionNucleic Acids Research, 1991
- The Clearance and Degradation of Oligodeoxynucleotides Following Intravenous Injection into RabbitsAntisense Research and Development, 1991
- Antisense AntiviralsAntisense Research and Development, 1991
- The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryosNucleic Acids Research, 1990
- High-performance liquid chromatographic analysis of phosphorothioate analogues of oligodeoxynucleotides in biological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1990